SB 622, as amended, Hernandez. Optometry.
The Optometry Practice Act provides for the licensure and regulation of the practice of optometry by the State Board of Optometry, and defines the practice of optometry to include, among other things, the prevention and diagnosis of disorders and dysfunctions of the visual system, and the treatment and management of certain disorders and dysfunctions of the visual system, as well as the provision of rehabilitative optometric services, and doing certain things, including, but not limited to, the examination of the human eyes, the determination of the powers or range of human vision, and the prescribing of contact and spectacle lenses. Existing law authorizes an optometrist certified to use therapeutic pharmaceutical agents to diagnose and treat specified conditions, use specified pharmaceutical agents, and order specified diagnostic tests. The act requires optometrists treating or diagnosing eye disease, as specified, to be held to the same standard of care to which physicians and surgeons and osteopathic physician and surgeons are held.begin insert The act requires an optometrist, in certain circumstances, to refer a patient to an opthamologist or a physician and surgeon, including when a patient has been diagnosed with a central corneal ulcer and the central corneal ulcer has not improved within 48 hours of the diagnosis.end insert The act makes a violation of any of its provisions a crime. All moneys collected pursuant to the act, except where otherwise provided, are deposited in the Optometry Fund and continuously appropriated to the board to carry out the act.
This bill would revise and recast those provisions.begin insert The bill would delete certain requirements that an
optometrist refer a patient to an opthamologist or a physician and surgeon, including when a patient has been diagnosed with a central corneal ulcer and the central corneal ulcer has not improved within 48 hours of the diagnosis.end insert The bill would additionally define the practice of optometry as the provision of habilitative optometric services, and would authorize the board to allow optometrists to use nonsurgical technology to treat any authorized condition under the act. The bill wouldbegin insert additionallyend insert authorize an optometristbegin insert certifiedend insert to usebegin delete diagnosticend deletebegin insert therapeuticend insert pharmaceuticalbegin delete agents, as specified, including, but not limited to, oral and topical diagnostic pharmaceutical agents that are not controlled substances.end deletebegin insert
agents to collect a blood specimen by finger prick method, to perform skin tests, as specified, to diagnose ocular allergies, and to use mechanical lipid extraction of meibomian glands and nonsurgical techniques.end insert
The bill wouldbegin delete authorize an optometrist to independently initiate and
administer vaccines, as specified, for a person 3 years of age and older, if the optometrist meets certain requirements, including, but not limited to,end deletebegin insert require the board to grant an optometrist certified to treat glaucoma a certificate for the use of specified immunizations if certain conditions are met, including, among others,end insert thatbegin delete he or sheend deletebegin insert the optometristend insert is certified in basic lifebegin delete support for health care professionals.end deletebegin insert support.end insert The bill would additionally authorize an optometrist certified to use therapeutic
pharmaceutical agents to, among other things, be certified to use anterior segment lasers, as specified, and to be certified to perform specified minor procedures, as specified, if certain requirements are met.
The bill would require the board to charge a fee of not more than $150 to cover the reasonable regulatory cost of certifying an optometrist to use anterior segmentbegin delete lasers.end deletebegin insert lasers, a fee of not more than $150 to cover the reasonable regulatory cost of certifying an optometrist to use minor procedures, and end insertbegin inserta fee of not more than $100 to cover the reasonable regulatory cost of certifying an optometrist to use immunizations.end insert Because this bill would increase those
moneys deposited in a continuously appropriated fund, it would make an appropriation.
Existing law establishes the Office of Statewide Health Planning and Development, which is vested with all the duties, powers, responsibilities, and jurisdiction of the State Department of Public Health relating to health planning and research development.
end insertbegin insertThis bill would declare the intent of the Legislature that the Office of Statewide Health Planning designate a pilot project to test, demonstrate, and evaluate expanded roles for optometrists in the performance of management and treatment of diabetes mellitus, hypertension, and hypercholesterolemia.
end insertBecause a violation of the act is a crime, this bill would expand the scope of an existing crime and would, therefore, result in a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Vote: majority. Appropriation: yes. Fiscal committee: yes. State-mandated local program: yes.
The people of the State of California do enact as follows:
Section 3041 of the Business and Professions
2Code is amended to read:
(a) The practice of optometry includes the prevention
4and diagnosis of disorders and dysfunctions of the visual system,
5and the treatment and management of certain disorders and
6dysfunctions of the visual system, as well as the provision of
7habilitative or rehabilitative optometric services, and is the doing
8of any or all of the following:
9(1) The examination of the human eye or eyes, or its or their
10appendages, and the analysis of the human vision system, either
11subjectively or objectively.
12(2) The determination of the powers or range of human vision
13and the accommodative and refractive states of the human eye or
14eyes, including the scope of its or their functions and general
15condition.
P4 1(3) The prescribing or directing the use of, or using, any optical
2device in connection with ocular exercises, visual training, vision
3training, or orthoptics.
4(4) The prescribing of contact and spectacle lenses for, or the
5fitting or adaptation of contact and spectacle lenses to, the human
6eye, including lenses that may be classified as drugs or devices by
7any law of the United States or of this state.
8(5) The use of topical pharmaceutical agents for the purpose of
9the examination of the human eye or eyes for any disease or
10pathological condition.
11(b) The State Board of Optometry shall, by regulation, establish
12educational and examination requirements for licensure to ensure
13the competence of optometrists to practice pursuant to thisbegin delete chapter.end delete
14begin insert
chapter, except as specified in Section 3041.3 related to the use
15of anterior segment lasers and in Section 3041.4 related to minor
16procedures.end insert Satisfactory completion of the required educational
17and examination requirements shall be a condition for the issuance
18of an original optometrist license or required certifications pursuant
19to this chapter.
20(c) The board maybegin delete authorizeend deletebegin insert
promulgate regulations authorizingend insert
21 optometrists to usebegin insert noninvasive,end insert nonsurgical technology to treat a
22condition authorized by this chapter.begin insert The board shall require a
23licensee to take a minimum of four hours of education courses on
24the new technology and perform an appropriate number of
25complete clinical procedures on live human patients to qualify to
26use each new technology authorized by the board pursuant to this
27subdivision.end insert
Section 3041.1 of the Business and Professions Code
29 is repealed.
Section 3041.1 is added to the Business and Professions
31Code, to read:
(a) (1) An optometrist who is certified to use
33therapeutic pharmaceutical agents pursuant to this section may
34also diagnose and treat the human eye or eyes, or any of its or their
35appendages, for all of the following conditions:
36(A) Through medical treatment, infections of the anterior
37segment and adnexa.
38(B) Ocular allergies of the anterior segment and adnexa.
39(C) Ocular inflammation that is nonsurgical in cause, except
40when comanaged with the treating physician and surgeon.
P5 1(C) Ocular inflammation, nonsurgical in cause except when
2comanaged with the treating physician and surgeon, limited to
3inflammation resulting from traumatic iritis, peripheral corneal
4inflammatory keratitis, episcleritis, and unilateral nonrecurrent
5nongranulomatous idiopathic iritis in patients over 18 years of
6age.
7(D) Traumatic or recurrent conjunctival or corneal abrasions
8and erosions.
9(E) Corneal and conjunctival surface disease and dry eyes
10disease.
11(F) Ocular pain that is nonsurgical in cause, except when
12comanaged with the treating physician and surgeon.
13(G) begin deleteEyelid disorders, including, but not limited to, hypotrichosis begin insert
Hypotrichosis and blepharitis.end insert
14and blepharitis.end delete
15(2) For purposes of this section, “treat” means the use of
16therapeutic pharmaceutical agents, as described in subdivision (b),
17and the procedures described in subdivision (c).
18(3) For purposes of this chapter, “adnexa” means ocular adnexa.
19(b) In diagnosing and treating the conditions listed in subdivision
20(a), an optometrist certified to use therapeutic pharmaceutical
21agents pursuant to this section may use all of the following
22begin delete diagnostic andend delete therapeutic pharmaceutical agents:
23(1) Oral and topical diagnostic and therapeutic pharmaceutical
24agents that are not controlled substances. The use of pharmaceutical
25agents shall be limited to the use for which the drug has been
26approved for marketing by the federal Food and Drug
27Administration (FDA).
28(2) Notwithstanding paragraph (1), an optometrist certified to
29use therapeutic pharmaceutical agents may use a drug in a way for
30which the drug has not been approved for marketing by the FDA
31if all of the following
requirements are met:
32(A) The drug is approved by the FDA.
33(B) The drug has been recognized for treatment of the condition
34by either of the following:
35(i) The American Hospital Formulary Service’s Drug
36Information.
37(ii) Two articles from major peer reviewed medical journals
38that present data supporting the proposed off-label use or uses as
39generally safe and effective, unless there is clear and convincing
P6 1contradictory evidence presented in a major peer reviewed
medical
2journal.
3(3) Notwithstanding paragraph (1), codeine with compounds
4and hydrocodone with compounds as listed in the California
5Uniform Controlled Substances Act (Division 10 (commencing
6with Section 11000) of the Health and Safety Code) and
the federal
7Controlled Substances Act (21 U.S.C. Sec. 801, et seq.) may be
8used. The use of these controlled substances shall be limited to
9five days.
10(1) Topical pharmaceutical agents for the purpose of the
11examination of the human eye or eyes for any disease or
12pathological condition, including, but not limited to, topical
13miotics.
14(2) Topical lubricants.
end insertbegin insert
15(3) Antiallergy agents. In using topical steroid medication for
16the treatment of ocular allergies, an optometrist shall consult with
17an
ophthalmologist if the patient’s condition worsens 21 days after
18diagnosis.
19(4) Topical and oral anti-inflammatories.
end insertbegin insert20(5) Topical antibiotic agents.
end insertbegin insert21(6) Topical hyperosmotics.
end insertbegin insert
22(7) Topical and oral antiglaucoma agents pursuant to the
23certification process defined in Section 3041.2.
24(8) Nonprescription medications used for the rational treatment
25of an ocular disorder.
26(9) Oral antihistamines.
end insertbegin insert27(10) Prescription oral nonsteroidal anti-inflammatory agents.
end insertbegin insert28(11) Oral antibiotics for medical treatment of ocular disease.
end insertbegin insert
29(12) Topical and oral antiviral
medication for the medical
30treatment of herpes simplex viral keratitis, herpes simplex viral
31conjunctivitis, periocular herpes simplex viral dermatitis, varicella
32zoster viral keratitis, varicella zoster viral conjunctivitis, and
33periocular varicella zoster viral dermatitis.
34(13) Oral analgesics that are not controlled substances.
end insertbegin insert
35(14) Codeine with compounds and hydrocodone with compounds
36as listed in the California Uniform Controlled Substances Act
37(Division 10 (commencing with Section 11000) of the Health and
38Safety Code) and the United States Uniform Controlled Substances
39Act (21 U.S.C. Sec. 801 et seq.). The use of these agents shall be
P7 1limited to five days, with a
referral to an ophthalmologist if the
2pain persists.
3(c) An optometrist who is certified to use therapeutic
4pharmaceutical agents pursuant to this section may also perform
5all of the following:
6(1) Corneal scraping with cultures.
7(2) Debridement of corneal epithelia.
8(3) Mechanical epilation.
9(4) Collection of a blood specimen by finger prick method or
10venipuncture for testing patients suspected of having diabetes.
11(5) Suture removal, with prior consultation with the treating
12health care provider.
13(6) Treatment or removal of sebaceous cysts by expression.
14(7) Administration of oral fluorescein to patients suspected as
15having diabetic retinopathy.
16(8) Use of an auto-injector to counter anaphylaxis.
17(9) Ordering of
clinical laboratory and imaging tests related to
18the practice of optometry.
19(10) A clinical laboratory test or examination classified as
20waived under CLIA and related to the practice of optometry.
21(9) Ordering of smears, cultures, sensitivities, complete blood
22count, mycobacterial culture, acid fast stain, urinalysis, tear fluid
23analysis, and X-rays necessary for the diagnosis of conditions or
24diseases of the eye or adnexa. An optometrist may order other
25types of images subject to prior consultation with the appropriate
26physician and surgeon.
27(10) A clinical laboratory test or examination classified as
28waived under the Clinical Laboratory Improvement Amendments
29of 1988 (CLIA)(42 U.S.C. Sec. 263a; Public Law 100-578) or any
30regulations adopted pursuant to CLIA, and that are necessary for
31the diagnosis of conditions and diseases of the eye or adnexa, or
32if otherwise specifically authorized by this chapter.
33(11) Skin test to diagnose ocular allergies. Skin tests shall be
34limited to the superficial lawyer of the skin.
35(12) Punctal occlusion by plugs, excluding laser, diathermy,
36cryotherapy, or other means constituting surgery as defined in this
37chapter.
38(13) The prescription of therapeutic contact lenses, diagnostic
39contact lenses, or biological or
technological cornealbegin delete devices.end delete
P8 1begin insert devices that diagnose or treat a condition authorized under this
2chapter.end insert
3(14) Removal of foreign bodies from the cornea, eyelid, and
4conjunctiva with any appropriate instrument other than abegin delete scalpel begin insert scalpel.end insert Corneal foreign bodies shall be nonperforating,
5or needle.end delete
6be no deeper than the midstroma, and require no surgical repair
7upon removal.
8(15) For patients over 12 years of age, lacrimal irrigation and
9
dilation, excluding probing of the nasal lacrimal tract. The board
10shall certify any optometrist who graduated from an accredited
11school of optometry before May 1, 2000, to perform this procedure
12after submitting proof of satisfactory completion and confirmation
13of 10 procedures under the supervision of an ophthalmologist or
14optometrist who is certified in lacrimal irrigation and dilation. Any
15optometrist who graduated from an accredited school of optometry
16on or after May 1, 2000, shall be exempt from the certification
17requirement contained in this paragraph.
18(16) Use of mechanical lipid extraction of meibomian glands
19and nonsurgical techniques.
20(17) Notwithstanding subdivision (b), administration of
21injections for the diagnoses or treatment of conditions of the eye
22and adnexa, excluding intraorbital injections and injections
23administered for cosmetic effect, provided that the optometrist has
24satisfactorily received four hours of continuing education on
25performing all injections authorized by this paragraph.
26(d) In order to be certified to use therapeutic pharmaceutical
27agents and authorized to diagnose and treat the conditions listed
28in this section, an optometrist shall apply for a certificate from the
29board and meet all requirements imposed by the board.
30(e) The board shall grant a certificate to use therapeutic
31pharmaceutical agents to any applicant who graduated from a
32California accredited school of optometry prior to January 1, 1996,
33is licensed as an optometrist in California, and meets all of the
34following requirements:
35(1) Satisfactorily completes a didactic course of no less than 80
36classroom hours in the diagnosis, pharmacological, and other
37treatment and management of ocular disease
provided by either
38an accredited school of optometry in California or a recognized
39residency review committee in ophthalmology in California.
P9 1(2) Completes a preceptorship of no less than 65 hours, during
2a period of not less than two months nor more than one year, in
3either an ophthalmologist’s office or an optometric clinic. The
4training received during the preceptorship shall be on the diagnosis,
5treatment, and management of ocular, systemic disease. The
6preceptor shall certify completion of the preceptorship.
7Authorization for the ophthalmologist to serve as a preceptor shall
8be provided by an accredited school of optometry in California,
9or by a recognized residency review committee in ophthalmology,
10and the preceptor shall be licensed as an ophthalmologist in
11California, board certified in ophthalmology, and in good standing
12with the Medical Board of California. The
individual serving as
13the preceptor shall schedule no more than three optometrist
14applicants for each of the required 65 hours of the preceptorship
15program. This paragraph shall not be construed to limit the total
16number of optometrist applicants for whom an individual may
17serve as a preceptor, and is intended only to ensure the quality of
18the preceptorship by requiring that the ophthalmologist preceptor
19schedule the training so that each applicant optometrist completes
20each of the 65 hours of the preceptorship while scheduled with no
21more than two other optometrist applicants.
22(3) Successfully completes a minimum of 20 hours of
23self-directed education.
24(4) Passes the National Board of Examiners in Optometry’s
25“Treatment and Management of Ocular Disease”
examination or,
26in the event this examination is no longer offered, its equivalent,
27as determined by the State Board of Optometry.
28(5) Passes the examination issued upon completion of the
2980-hour didactic course required under paragraph (1) and provided
30by the accredited school of optometry or residency program in
31ophthalmology.
32(6) When any or all of the requirements contained in paragraph
33(1), (4), or (5) have been satisfied on or after July 1, 1992, and
34before January 1, 1996, an optometrist shall not be required to
35fulfill the satisfied requirements in order to obtain certification to
36use therapeutic pharmaceutical agents. In order for this paragraph
37to apply to the requirement contained in paragraph (5), the didactic
38examination that the applicant
successfully completed shall meet
39equivalency standards, as determined by the board.
P10 1(7) Any optometrist who graduated from an accredited school
2of optometry on or after January 1, 1992, and before January 1,
31996, shall not be required to fulfill the requirements contained in
4paragraphs (1), (4), and (5).
5(f) The board shall grant a certificate to use therapeutic
6pharmaceutical agents to any applicant who graduated from a
7California accredited school of optometry on or after January 1,
81996, who is licensed as an optometrist in California, and who
9meets all of the following requirements:
10(1) Passes the National Board of Examiners in Optometry’s
11national board examination, or its
equivalent, as determined by
12the State Board of Optometry.
13(2) Of the total clinical training required by a school of
14optometry’s curriculum, successfully completed at least 65 of those
15hours on the diagnosis, treatment, and management of ocular,
16systemic disease.
17(3) Is certified by an accredited school of optometry as
18competent in the diagnosis, treatment, and management of ocular,
19systemic disease to the extent authorized by this section.
20(4) Is certified by an accredited school of optometry as having
21completed at least 10 hours of experience with a board-certified
22ophthalmologist.
23(g) The board shall grant a certificate to use therapeutic
24pharmaceutical agents to any applicant who is an optometrist who
25obtained his or her license outside of
California if he or she meets
26all of the requirements for an optometrist licensed in California to
27be certified to use therapeutic pharmaceutical agents.
28(1) In order to obtain a certificate to use therapeutic
29pharmaceutical agents, any optometrist who obtained his or her
30license outside of California and graduated from an accredited
31school of optometry prior to January 1, 1996, shall be required to
32fulfill the requirements set forth in subdivision (e). In order for the
33applicant to be eligible for the certificate to use therapeutic
34pharmaceutical agents, the education he or she received at the
35accredited out-of-state school of optometry shall be equivalent to
36the education provided by any accredited school of optometry in
37California for persons who graduated before January 1, 1996. For
38those out-of-state applicants who request that any of the
39requirements contained in subdivision (e) be waived based on
40fulfillment of the requirement in another
state, if the board
P11 1determines that the completed requirement was equivalent to that
2required in California, the requirement shall be waived.
3(2) In order to obtain a certificate to use therapeutic
4pharmaceutical agents, any optometrist who obtained his or her
5license outside of California and who graduated from an accredited
6school of optometry on or after January 1, 1996, shall be required
7to fulfill the requirements set forth in subdivision (f). In order for
8the applicant to be eligible for the certificate to use therapeutic
9pharmaceutical agents, the education he or she received by the
10accredited out-of-state school of optometry shall be equivalent to
11the education provided by any accredited school of optometry for
12persons who graduated on or after January 1, 1996. For those
13out-of-state applicants who request that any of the requirements
14contained in subdivision (f) be waived based on fulfillment of the
15requirement in another state, if the
board determines that the
16completed requirement was equivalent to that required in
17California, the requirement shall be waived.
18(3) The State Board of Optometry shall decide all issues relating
19to the equivalency of an optometrist’s education or training under
20this subdivision.
21(h) Other than for prescription ophthalmic devices described in
22subdivision (b) of Section 2541, any dispensing of a therapeutic
23pharmaceutical agent by an optometrist shall be without charge.
24(i) Except as authorized by this chapter, the practice of
25optometry does not include performing surgery. “Surgery” means
26any procedure in which human tissue is cut, altered, or otherwise
27infiltrated by mechanical or laser means.
“Surgery” does not
28include those procedures specified in subdivision (c). This section
29does not limit an optometrist’s authority to utilize diagnostic laser
30and ultrasound technology within his or her scope of practice.
31(j) In an emergency, an optometrist shall stabilize, if possible,
32and immediately refer any patient who has an acute attack of angle
33closure to an ophthalmologist.
Section 3041.2 of the Business and Professions Code
35 is repealed.
Section 3041.2 is added to the Business and Professions
37Code, to read:
(a) For purposes of this chapter, “glaucoma” means
39any of the following:
40(1) All primary open-angle glaucoma.
P12 1(2) Exfoliation and pigmentary glaucoma.
2(3) Increase in intraocular pressure caused by steroidbegin delete medication.end delete
3begin insert
medication prescribed by the optometrist.end insert
4(4) Increase in intraocular pressure caused by steroid
5medication not prescribed by the optometrist, after consultation
6and treatment approval by the prescribing physician.
7(b) An optometrist certified pursuant to Section 3041.1 shall be
8certified for the treatment of glaucoma, as described in subdivision
9(a), in patients over 18 years of age after the optometrist meets the
10following applicable requirements:
11(1) For licensees who graduated from an accredited school of
12optometry on or after May 1, 2008, submission of proof of
13graduation from that institution.
14(2) For licensees who were certified to treat glaucoma under
15this section prior to January 1, 2009, submission of proof of
16completion of that certification program.
17(3) For licensees who completed a didactic course of not less
18than 24 hours in the diagnosis, pharmacological, and other
19treatment and management of glaucoma, submission of proof of
20satisfactory completion of the case management requirements for
21certification established by the board.
22(4) For licensees who graduated from an accredited school of
23optometry on or before May 1, 2008, and are not described in
24paragraph (2) or (3), submission of proof of satisfactory completion
25of the requirements for certification established by the board.
Section 3041.3 of the Business and Professions Code
27 is repealed.
Section 3041.3 is added to the Business and Professions
29Code, to read:
(a) For the purposes of this chapter, “anterior segment
31laser” means any of the following:
32(1) Therapeutic lasers appropriate for treatment of glaucoma.
33(2) Notwithstanding subdivision (a) of Section 3041.2,
34peripheral iridotomy for the prophylactic treatment of angle closure
35glaucoma.
36(3) Therapeutic lasers used for posterior capsulotomy secondary
37to cataract surgery.
38(b) An optometrist certified to treat glaucoma pursuant to
39Section 3041.2 shall be additionally certified for the use of anterior
40segment lasers after submitting proof of satisfactory
completion
P13 1of a course that is approved by the board, provided by an accredited
2school of optometry, and developed in consultation with an
3ophthalmologist who has experience educating optometric students.
4begin insert The board shall issue a certificate pursuant to this section only to
5an optometrist that has graduated from an approved school of
6optometry.end insert
7(1) The board-approved course shall bebegin delete a minimum of 16end deletebegin insert at
8least 25end insert hours in length, and include a test for competency of the
9following:
10(A) Laser physics, hazards, and safety.
11(B) Biophysics of laser.
12(C) Laser application in clinical optometry.
13(D) Laser tissue interactions.
14(E) Laser indications, contraindications, and potential
15complications.
16(F) Gonioscopy.
17(G) Laser therapy for open-angle glaucoma.
18(H) Laser therapy for angle closure glaucoma.
19(I) Posterior capsulotomy.
20(J) Common complications of the lids, lashes, and lacrimal
21system.
22(K) Medicolegal aspects of anterior segment procedures.
23(L) Peripheral iridotomy.
24(M) Laser trabeculoplasty.
25(2) The school of optometry shall require each applicant for
26certification to perform a sufficient number ofbegin insert completeend insert anterior
27segment laser procedures to verify that the applicant has
28demonstrated competency to practice independently. At a
29minimum, each applicant shall completebegin delete 14end deletebegin insert
24end insert anterior segment
30laser procedures on livebegin delete humans.end deletebegin insert
humans as follows:end insert
31(A) Eight YAG capsulotomy procedures.
end insertbegin insert32(B) Eight laser trabeculoplasty procedures.
end insertbegin insert33(C) Eight peripheral iridotomy procedures.
end insert
34(c) The board, by regulation, shall set the fee for issuance and
35renewal of a certificate authorizing the use of anterior segment
36lasers at an amount no higher than the reasonable cost of regulating
37anterior segment laser certified optometrists pursuant to this
38section. The fee shall not exceed one hundred fifty dollars ($150).
39(d) An optometrist certified to use anterior segment lasers
40pursuant to this section shall complete four hours of continuing
P14 1education on anterior segment lasers as part of the required 50
2hours of continuing education required to be completed every two
3years on the diagnosis, treatment, and management of glaucoma.
Section 3041.4 is added to the Business and Professions
5Code, to read:
(a) For the purposes of this chapter, “minor procedure”
7means either of the following:
8(1) Removal, destruction, or drainage of lesions of the eyelid
9and adnexa clinically evaluated by the optometrist to be
10noncancerous, not involving the eyelid margin, lacrimal supply or
11drainage systems, no deeper than the orbicularis muscle, and
12smaller than five millimeters in diameter.
13(2) Closure of a wound resulting from a procedure described in
14paragraph (1).
15(3) Administration of injections for the diagnoses or treatment
16of conditions of the
eye and adnexa authorized by this chapter,
17excluding intraorbital injections and injections administered for
18cosmetic effect.
19(4) “Minor procedures” does not include blepharoplasty or
20other cosmetic surgery procedures that reshape normal structures
21of the body in order to improve appearance and self-esteem.
22(b) An optometrist certified to treat glaucoma pursuant to
23Section 3041.2 shall be additionally certified to perform minor
24procedures after submitting proof of satisfactory completion of a
25course that is approved by the board, provided by an accredited
26school of optometry, and developed in consultation with an
27ophthalmologist who has experience teaching optometric students.
28begin insert The board shall issue a certificate pursuant to this section only to
29an optometrist that has
graduated from an approved school of
30optometry.end insert
31(1) The board-approved course shall bebegin delete a minimum of 32 hoursend delete
32begin insert at least 25 hoursend insert in length and include a test for competency of
33the following:
34(A) Minor surgical procedures.
35(B) Overview of surgical instruments, asepsis, and the state and
36federal Occupational Safety and Health Administrations.
37(C) Surgical anatomy of the eyelids.
38(D) Emergency surgical procedures.
39(E) Chalazion management.
40(F) Epiluminescence microscopy.
P15 1(G) Suture techniques.
2(H) Local anesthesia techniques and complications.
3(I) Anaphylaxsis and other office emergencies.
4(J) Radiofrequency surgery.
5(K) Postoperative wound care.
begin insert6(L) Injection techniques.
end insert
7(2) The school of optometry shall require each applicant for
8certification to perform a sufficient number of minor
procedures
9to verify that the applicant has demonstrated competency to
10practice independently. At a minimum, each applicant shallbegin insert perform
1132end insert completebegin delete fiveend delete minor procedures on live humans.
12(c) The board, by regulation, shall set the fee for issuance and
13renewal of a certificate authorizing the use of minor procedures
14at an amount no greater than the reasonable cost of regulating
15minor procedure certified optometrists pursuant to this section.
16The fee shall not exceed one hundred fifty dollars ($150).
17(d) An optometrist certified to perform minor procedures
18pursuant to Section 3041.1 shall complete five hours of
continuing
19education on the diagnosis, treatment, and management of lesions
20of the eyelid and adnexa as part of the 50 hours of continuing
21education required every two years in Section 3059.
Section 3041.5 is added to the Business and Professions
23Code, to read:
(a) An optometrist may independently initiate and
25administer vaccines listed on the routine immunization schedules
26recommended by the federal Advisory Committee on Immunization
27Practices (ACIP), in compliance with individual ACIP vaccine
28recommendations, and published by the federal Centers for Disease
29Control and Prevention (CDC) for persons three years of age and
30older.
31(b) In order to initiate and administer an immunization described
32in subdivision (a), an optometrist shall do all of the following:
33(1) Complete an immunization training program endorsed by
34the CDC or the Accreditation Council
for Pharmacy Education
35that, at a minimum, includes hands-on injection technique, clinical
36evaluation of indications and contraindications of vaccines, and
37the recognition and treatment of emergency reactions to vaccines,
38and shall maintain that training.
39(2) Be certified in basic life support for health care professionals.
P16 1(3) Comply with all state and federal recordkeeping and
2reporting requirements, including providing documentation to the
3patient’s primary care provider and entering information in the
4appropriate immunization registry designated by the immunization
5branch of the State Department of Public Health.
begin insertSection 3041.5 is added to the end insertbegin insertBusiness and Professions
7Codeend insertbegin insert, to read:end insert
(a) The board shall grant to an optometrist a
9certificate for the use of immunizations described in subdivision
10(b), if the optometrist is certified pursuant to Section 3041.2 and
11after the optometrist meets all of the following requirements:
12(1) Completes an immunization training program endorsed by
13the federal Centers for Disease Control (CDC) that, at a minimum,
14includes hands-on injection technique, clinical evaluation of
15indications and contraindications of vaccines, and the recognition
16and treatment of emergency reactions to vaccines, and maintains
17that training.
18(2) Is certified in basic life support.
19(3) Complies with all state and federal recordkeeping and
20reporting requirements, including providing documentation to the
21patient’s primary care provider and entering information in the
22appropriate immunization registry designated by the immunization
23branch of the State Department of Public Health.
24(b) For the purposes of this section, “immunization” means the
25administration of immunizations for influenza, herpes zoster virus,
26and pneumococcus in compliance with individual Advisory
27Committee on Immunization Practices (ACIP) vaccine
28recommendations published by the CDC for persons 18 years of
29age or older.
30(c) The board, by regulation, shall set the fee for issuance and
31renewal of a certificate for the use of immunizations at the
32reasonable cost of regulating immunization certified optometrists
33pursuant to this section. The fee shall not exceed one hundred
34dollars
($100).
Section 3041.6 is added to the Business and
36Professions Code, to read:
An optometrist licensed under this chapter is subject
38to the provisions of Section 2290.5 for purposes of practicing
39telehealth.
Section 3041.7 is added to the Business and
2Professions Code, to read:
Optometrists diagnosing or treating eye disease shall
4be held to the same standard of care to which physicians and
5surgeons and osteopathic physicians and surgeons are held. An
6optometrist shall consult with and, if necessary, refer to a physician
7and surgeon or other appropriate health care provider when a
8situation or condition occurs that is beyond the optometrist’s scope
9of practice.
Section 3041.8 is added to the Business and
11Professions Code, to read:
It is the intent of the Legislature that the Office of
13Statewide Health Planning and Development, under the Health
14Workforce Pilot Projects Program, designate a pilot project to test,
15demonstrate, and evaluate expanded roles for optometrists in the
16performance of management and treatment of diabetes mellitus,
17hypertension, and hypercholesterolemia.
begin insertSection 3110 of the end insertbegin insertBusiness and Professions Codeend insert
19begin insert is amended to read:end insert
The board may take action against any licensee who is
21charged with unprofessional conduct, and may deny an application
22for a license if the applicant has committed unprofessional conduct.
23In addition to other provisions of this article, unprofessional
24conduct includes, but is not limited to, the following:
25(a) Violating or attempting to violate, directly or indirectly
26assisting in or abetting the violation of, or conspiring to violate
27any provision of this chapter or any of the rules and regulations
28adopted by the board pursuant to this chapter.
29(b) Gross negligence.
30(c) Repeated negligent acts. To be repeated, there must be two
31or more negligent acts or
omissions.
32(d) Incompetence.
33(e) The commission of fraud, misrepresentation, or any act
34involving dishonesty or corruption, that is substantially related to
35the qualifications, functions, or duties of an optometrist.
36(f) Any action or conduct that would have warranted the denial
37of a license.
38(g) The use of advertising relating to optometry that violates
39Section 651 or 17500.
P18 1(h) Denial of licensure, revocation, suspension, restriction, or
2any other disciplinary action against a health care professional
3license by another state or territory of the United States, by any
4other governmental agency, or by another California health care
5professional licensing board. A certified copy of the
decision or
6judgment shall be conclusive evidence of that action.
7(i) Procuring his or her license by fraud, misrepresentation, or
8mistake.
9(j) Making or giving any false statement or information in
10connection with the application for issuance of a license.
11(k) Conviction of a felony or of any offense substantially related
12to the qualifications, functions, and duties of an optometrist, in
13which event the record of the conviction shall be conclusive
14evidence thereof.
15(l) Administering to himself or herself any controlled substance
16or using any of the dangerous drugs specified in Section 4022, or
17using alcoholic beverages to the extent, or in a manner, as to be
18dangerous or injurious to the person applying for a license or
19holding a license under this
chapter, or to any other person, or to
20the public, or, to the extent that the use impairs the ability of the
21person applying for or holding a license to conduct with safety to
22the public the practice authorized by the license, or the conviction
23of a misdemeanor or felony involving the use, consumption, or
24self-administration of any of the substances referred to in this
25subdivision, or any combination thereof.
26(m) (1) Committing or soliciting an act punishable as a sexually
27related crime, if that act or solicitation is substantially related to
28the qualifications, functions, or duties of an optometrist.
29(2) Committing any act of sexual abuse, misconduct, or relations
30with a patient. The commission of and conviction for any act of
31sexual abuse, sexual misconduct, or attempted sexual misconduct,
32whether or not with a patient, shall be considered a crime
33
substantially related to the qualifications, functions, or duties of a
34licensee. This paragraph shall not apply to sexual contact between
35any person licensed under this chapter and his or her spouse or
36person in an equivalent domestic relationship when that licensee
37provides optometry treatment to his or her spouse or person in an
38equivalent domestic relationship.
39(3) Conviction of a crime that requires the person to register as
40a sex offender pursuant to Chapter 5.5 (commencing with Section
P19 1290) of Title 9 of Part 1 of the Penal Code. A conviction within
2the meaning of this paragraph means a plea or verdict of guilty or
3a conviction following a plea of nolo contendere. A conviction
4described in this paragraph shall be considered a crime substantially
5related to the qualifications, functions, or duties of a licensee.
6(n) Repeated acts of excessive prescribing, furnishing, or
7
administering of controlled substances or dangerous drugs specified
8in Section 4022, or repeated acts of excessive treatment.
9(o) Repeated acts of excessive use of diagnostic or therapeutic
10procedures, or repeated acts of excessive use of diagnostic or
11treatment facilities.
12(p) The prescribing, furnishing, or administering of controlled
13substances or drugs specified in Section 4022, or treatment without
14a good faith prior examination of the patient and optometric reason.
15(q) The failure to maintain adequate and accurate records
16relating to the provision of services to his or her patients.
17(r) Performing, or holding oneself out as being able to perform,
18or offering to perform, any professional services beyond the scope
19of the license authorized by this
chapter.
20(s) The practice of optometry without a valid, unrevoked,
21unexpired license.
22(t) The employing, directly or indirectly, of any suspended or
23unlicensed optometrist to perform any work for which an optometry
24license is required.
25(u) Permitting another person to use the licensee’s optometry
26license for any purpose.
27(v) Altering with fraudulent intent a license issued by the board,
28or using a fraudulently altered license, permit certification or any
29registration issued by the board.
30(w) Except for good cause, the knowing failure to protect
31patients by failing to follow infection control guidelines of the
32board, thereby risking transmission of bloodborne infectious
33diseases from
optometrist to patient, from patient to patient, or
34from patient to optometrist. In administering this subdivision, the
35board shall consider the standards, regulations, and guidelines of
36the State Department of Public Health developed pursuant to
37Section 1250.11 of the Health and Safety Code and the standards,
38guidelines, and regulations pursuant to the California Occupational
39Safety and Health Act of 1973 (Part 1 (commencing with Section
406300) of Division 5 of the Labor Code) for preventing the
P20 1transmission of HIV, hepatitis B, and other bloodborne pathogens
2in health care settings. As necessary, the board may consult with
3the Medical Board of California, the Board of Podiatric Medicine,
4the Board of Registered Nursing, and the Board of Vocational
5Nursing and Psychiatric Technicians, to encourage appropriate
6consistency in the implementation of this subdivision.
7(x) Failure or refusal to comply with a request for the clinical
8records of a
patient, that is accompanied by that patient’s written
9authorization for release of records to the board, within 15 days
10of receiving the request and authorization, unless the licensee is
11unable to provide the documents within this time period for good
12cause.
13(y) Failure to refer a patient to an appropriatebegin delete physician in either
14of the following circumstances:end delete
15begin delete(1)end deletebegin delete end deletebegin deleteWhere end deletebegin insert physician ifend insert an examination of the eyes indicates a
16substantial likelihood of any pathology
that requires the attention
17of that physician.
18(2) As required by subdivision (c) of Section 3041.
end deleteNo reimbursement is required by this act pursuant to
21Section 6 of Article XIII B of the California Constitution because
22the only costs that may be incurred by a local agency or school
23district will be incurred because this act creates a new crime or
24infraction, eliminates a crime or infraction, or changes the penalty
25for a crime or infraction, within the meaning of Section 17556 of
26the Government Code, or changes the definition of a crime within
27the meaning of Section 6 of Article XIII B of the California
28Constitution.
O
97